0001563355-14-000001.txt : 20140710 0001563355-14-000001.hdr.sgml : 20140710 20140709191056 ACCESSION NUMBER: 0001563355-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140710 DATE AS OF CHANGE: 20140709 EFFECTIVENESS DATE: 20140710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hera Therapeutics Inc. CENTRAL INDEX KEY: 0001563355 IRS NUMBER: 800865383 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-220678 FILM NUMBER: 14968094 BUSINESS ADDRESS: STREET 1: 14024 RUE SAINT RAPHAEL CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 415 983 1000 MAIL ADDRESS: STREET 1: 14024 RUE SAINT RAPHAEL CITY: DEL MAR STATE: CA ZIP: 92014 D 1 primary_doc.xml X0707 D LIVE 0001563355 Hera Therapeutics Inc. 14024 RUE SAINT RAPHAEL DEL MAR CA CALIFORNIA 92014-3043 858.342.5556 DELAWARE None None Corporation true 2012 Karl Y. Hostetler c/o Hera Therapeutics Inc. 14024 Rue Saint Raphael Del Mar CA CALIFORNIA 92014-3043 Executive Officer Director President, Chief Executive Officer and Chief Financial Officer Michael J. Sullivan c/o Pillsbury Winthrop Shaw Pittman, LLP Four Embarcadero Center, 22nd Floor San Francisco CA CALIFORNIA 94111 Executive Officer Secretary William L. Respess c/o Hera Therapeutics Inc. 14024 Rue Saint Raphael Del Mar CA CALIFORNIA 92014-3043 Director Michael D. Cannon c/o Hera Therapeutics Inc. 14024 Rue Saint Raphael Del Mar CA CALIFORNIA 92014-3043 Director Biotechnology Decline to Disclose 06b false 2014-06-24 false true false 0 1300000 1100000 200000 This filing pertains to the issuance of convertible promissory notes, the capital stock issuable upon conversion of such note and the common stock issuable upon conversion of such capital stock. false 14 0 0 0 false Hera Therapeutics Inc. /s/ Michael J. Sullivan Michael J. Sullivan Secretary 2014-07-09